Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 01.01.16 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 03.10.19 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Daniel Trepanier
PRN | Corporate Officer/Principal | - | 03.10.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 15.05.13 |
Timothy Block
BRD | Director/Board Member | 69 | 26.11.13 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 27.06.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 1 688 | 0 | 0 | 99,69 % |
Aktie B | 1 | 5 473 126 | 5 456 345 ( 99,69 %) | 0 | |
Aktie C | 0 | 85 581 | 0 | 0 |
Unternehmenskontakt
Hepion Pharmaceuticals, Inc.
399 Thornall Street 1st Floor
08837, Edison
+732 902 4000
http://www.hepionpharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+16.73% | 121 Mrd. | |
+13.04% | 107 Mrd. | |
-5.80% | 24.82 Mrd. | |
+1.69% | 22.48 Mrd. | |
-10.09% | 18.32 Mrd. | |
-40.52% | 16.33 Mrd. | |
-14.00% | 15.31 Mrd. | |
+1.18% | 14.08 Mrd. | |
+24.18% | 11.74 Mrd. |